FDA Investigator Jessica B Zachman
Jessica B Zachman has inspections in 13 countries as of 15 Mar 2024. Jessica B Zachman has collaborated with a combined 1297 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
61
Last Inspection Date:
15 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
Chile,
Greece,
Trinidad and Tobago,
United States of America,
Spain,
South Africa,
Japan,
Italy,
Australia,
New Zealand,
Vanuatu,
Thailand
Co-Investigator(s):
Aaron J Poloni,
Abigail A Andersen,
Adamsr,
Amy Kim,
Amy R Glynn,
Anthony E Keller, RPh,
Beau R Lamb,
Brant M Schroeder,
Bruce R Burrell,
Carr,
Carr Sharpe,
Clara E Santiago,
Crystal A Harlan,
Dana A Razzano,
David G Whitman,
Dennis R Hudson,
Devon M Shoop,
Dirk L Lincoln,
Elizabeth S Howell,
Eric J Reisenauer,
Eric L Scott,
Estefania Fernandez,
Gordon T Wales,
Helen J Hamaoka,
Hugh Grimoldby,
James S Cartwright,
Jamie M Bumpas,
Jazmine M Welcher,
Jean Brewer,
Jean C Colon Lopez,
Jeannine K Wooten,
Jeff A Gard,
Jeffrey J Leclair,
Jennifer A Bazergui,
Jessica B Clark,
John E Emmert,
John T Sproul,
Jonathan T Little,
Judy C Nepsa,
Kaitlyn R Kornberg,
Karen D Phung,
Karla J Gibler,
Karla K Gibler,
Katharine Chan,
Keegan B Mixon,
Kevin T Gerrity,
Lauren E Sexton,
Leongc,
Lesley A Swanson,
Lili M Carr,
Mabel M Lee,
Maridali De Leon Torres,
Mary M Finn,
Matthew B Thomaston,
Michael R Dominick,
Michael S Hudson,
Mikhail V Ovanesov, PhD,
Min Shanmabel Liu,
Nancy E Byerly,
Nancy E Doyle,
Natalie J Ayoub,
Nympha V Florendo,
Patrick R Brown,
Peter T Regan,
Rachel J Cantrell,
Robert D Ogan,
Samuel K Gibbons, Jr,
Samuel Rudnitsky,
Savini,
State Agency,
Stephen R Souza,
Steven M Galvez,
Tara M Aikens,
Timothy D Evans,
Tracy K Li,
Troy R Petrillo,
Valerie A Potopsingh,
Zachary P Wachlarowicz
Jessica B Zachman's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2021 | EIR | Crunch Pak, LLC - EIR, 2021-04-15 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more